CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
primary trial objective is to demonstrate that ODM-201 produces prostate-specific antigen (PSA) response rates at 24 weeks (defined as ≥80% ...
Phase 2
Villejuif, France and 11 other locations
This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisi...
Phase 1, Phase 2
Villejuif, France and 12 other locations
to assess the preliminary signs of antitumor activity of darolutamide plus radiation therapy in patients with unfavorable intermediate risk prostate...
Phase 2
Paris, France and 9 other locations
with surgery in patients with high-risk and/or locally advanced prostate cancer.In this trial, patients will be assigned in one of ...
Phase 2
Paris, France and 16 other locations
Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...
Phase 1
Paris, France and 17 other locations
the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...
Levallois-Perret, France and 28 other locations
RATIONALE: Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as triptorelin, may lessen the amount ...
Phase 3
Paris, France and 16 other locations
docetaxel with or without local radiotherapy with or without abiraterone acetate and prednisone in patient with metastatic hormone-naïve prostate...
Phase 3
Paris, France and 76 other locations
This is a multicenter, randomized, open label, phase III study comparing the efficacy and safety of apatulamide combined with concomitant prostate...
Phase 3
Sarcelles, France and 14 other locations
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Créteil, Île-de-France, France and 112 other locations
Clinical trials
Research sites
Resources
Legal